Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022.
暂无分享,去创建一个
M. Exline | Akram Khan | W. Self | A. Ginde | T. Rice | D. Hager | N. Shapiro | M. Gong | M. McMorrow | Yuwei Zhu | N. Mohr | K. Hart | A. Duggal | K. Gibbs | A. Lauring | E. Martin | J. Chappell | Carlos G. Grijalva | M. Gaglani | N. Halasa | H. Talbot | D. Douin | J. Casey | J. Steingrub | Steven Y. Chang | M. Tenforde | S. Ghamande | Jennie H. Kwon | I. Peltan | J. DeCuir | William B. Stubblefield | A. Mohamed | Anne P Frosch | Nida Qadir | H. Erickson | D. Surie | D. Files | A. Zepeski | Adrienne H Baughman | Kelsey N. Womack | Vasisht Srinivasan | M. Patel | T. McNeal | A. Shehu | C. Rivas | K. Adams | William S Bender | Sydney A Swan | Jennifer G. Wilson | N. Johnson | J. Kwon | Samuel M. Brown | Christopher Mallow | Levi Bonnell | Sydney A. Swan | A. Baughman | K. Womack | S. A. Swan | N. Qadir | S. Swan
[1] D. Montefiori,et al. A Bivalent Omicron-Containing Booster Vaccine against Covid-19 , 2022, The New England journal of medicine.
[2] L. Bekker,et al. Effectiveness and Durability of the BNT162b2 Vaccine against Omicron Sublineages in South Africa , 2022, The New England journal of medicine.
[3] G. Lozanski,et al. Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants , 2022, The New England journal of medicine.
[4] William F. Fadel,et al. Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022 , 2022, MMWR. Morbidity and mortality weekly report.